MANKIND PHARMA
Back to All Ratios
|
MANKIND PHARMA Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Core EBITDA Growth(%) | 38.76 | -7.14 | 20.14 | 17.54 | 58.34 |
What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?
Year | Core EBITDA Growth |
---|---|
Mar2024 | 38.76 |
Mar2023 | -7.14 |
Mar2022 | 20.14 |
Mar2021 | 17.54 |
Mar2020 | 58.34 |
How is Core EBITDA Growth of MANKIND PHARMA Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2024 | 38.76 | Positive | |
Mar2023 | -7.14 | Negative | |
Mar2022 | 20.14 | 14.82 | |
Mar2021 | 17.54 | -69.93 | |
Mar2020 | 58.34 | - |
Other Financial Ratios of MANKIND PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹101,363.4 Cr | 2.4% | 7.1% | 3.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 2.4% |
7.1% |
3.9% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses